P39 Compared With Reference Omalizumab in Chronic Spontaneous Urticaria: Results From a Double-Blind, Randomized, ...
Verywell Health on MSN6h
20 Effective Ways to Treat HivesMind-body therapies like meditation, psychotherapy, and deep breathing may help reduce stress levels, potentially reducing ...
Zacks.com on MSN5h
Kymera Provides Pipeline Objectives for 2025, Stock GainsKYMR outlines plans to advance its immunology candidates. As of Dec. 31, 2024, KYMR had $850 million in cash that should fund its operations into mid-2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback